Papers
1
Total Citations
1
H-Index
1
About
Dr. Soyoung Im is a leading figure in gynecologic oncology, with a specialized focus on fertility-sparing treatments for cervical cancer. Her work addresses the critical intersection of aggressive cancer management and reproductive preservation, particularly for younger patients diagnosed with early-stage disease. Dr. Im’s most cited research, a 2022 case study, explores a novel protocol combining neoadjuvant chemotherapy with a quick cisplatin-VP16 regimen followed by robotic radical trachelectomy for FIGO 2018 stage IB2 cervical cancer. This contribution is significant because it challenges the standard radical hysterectomy, offering a less invasive, fertility-preserving alternative without compromising oncologic outcomes. The study has garnered 1 citation, reflecting its emerging impact in a niche but vital area. Dr. Im’s work is particularly timely given the global trend of delayed childbearing, underscoring her commitment to advancing personalized, patient-centered care. Her research not only expands surgical options but also provides a framework for integrating chemotherapy with robotic techniques, setting a precedent for future trials. Through this work, Dr. Im is helping to redefine treatment paradigms, balancing survival with quality of life for women facing cervical cancer.
Research Focus
Key Achievements
Top Papers
- 1